NCT04334876View on ClinicalTrials.gov

Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers

NACompletedINTERVENTIONAL
Enrollment

571

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

November 1, 2020

Study Completion Date

January 1, 2021

Conditions
SARS-CoV-2
Interventions
DIAGNOSTIC_TEST

SARS-CoV-2 IgG Antibody Testing Kit

A, finger prick, at home test for SARS-CoV-2 IgG Antibodies.

Trial Locations (1)

46202

Indiana University Health Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT04334876 - Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers | Biotech Hunter | Biotech Hunter